Back to Clinical Trials
N/ARecruiting

Type 1 Diabetes Extension Study

Sponsored by National Institute of Allergy and Infectious Diseases (NIAID)

About this study

This is a multi-center, prospective, non-interventional study that focuses on the long- term effects following participation in selected ITN new-onset Type1 Diabetes Mellitus studies with immunomodulatory agents (T1DM, T1D). This observational study will: * follow participants to determine how long they continue to produce insulin, and * will also assess how changes in the immune system over time relate to the ability to produce insulin. This information could help design better therapies for type 1 diabetes in the future.

Depending upon a participant's level of insulin production, participation may be as short as one return visit or a maximum of five years. Evaluation visits will include: * Overall health assessments * Blood and urine collections * Mixed meal tolerance test (MMTTs) for certain participants, per protocol.

Where this study is enrolling (8)

  • Stanford University

    Stanford, California

    I'm interested

  • UCSF School of Medicine

    San Francisco, California

    I'm interested

  • University of Colorado School of Medicine: Barbara Davis Center for Diabetes

    Aurora, Colorado

    I'm interested

  • Indiana University Riley Hospital for Children

    Indianapolis, Indiana

    I'm interested

  • University of Iowa Health Care Division of Pediatric Endocrinology

    Iowa City, Iowa

    I'm interested
Show all 8 locations
Who can participate

Inclusion criteria

  • ✓Prior participant in an Immune Tolerance Network (ITN) executive committee approved T1DM study.
  • ✓Ability to sign informed consent/assent (as applicable for children).

Exclusion criteria

  • ✕Any medical condition that in the opinion of the principal investigator would interfere with safe completion of the trial; or
  • ✕Inability to comply with the study visit schedule and required assessments.

Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.

Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.

Trial data sourced from ClinicalTrials.gov.